Literature DB >> 23362176

Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease.

Andrea Gold1, Zorbey T Turkalp, David G Munoz.   

Abstract

BACKGROUND AND
OBJECTIVE: Alpha-synuclein (α-Syn) is immunohistochemically detectable in enteric neurons in some subjects. We determined its age distribution in the general autopsy population and in an age-matched subset investigated differences with Parkinson's (PD) and Alzheimer's diseases (AD).
METHODS: Archival autopsy samples of colon from 95 cases (77 general population, 10 PD, and 8 AD) were immunostained with monoclonal antibody KM51. α-Syn detectability was semiquantitatively graded 1 to 3.
RESULTS: α-Syn was detectable in 52% of the general population, and its level of expression did not change between ages 40 and 91. All PD subjects were α-Syn positive, with higher prevalence (P = 0.001) and grade (P = 0.003) than age-matched controls. AD subjects were no more likely to be α-Syn positive or have a higher grade than controls.
CONCLUSIONS: Either PD develops selectively in the enterically α-Syn-positive population subset or PD induces this expression. Absence of increased α-Syn expression in AD points to differences in pathogenesis.
© 2013 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23362176     DOI: 10.1002/mds.25298

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  46 in total

Review 1.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

2.  Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro.

Authors:  Nady Braidy; Wei-Ping Gai; Ying Hua Xu; Perminder Sachdev; Gilles J Guillemin; Xing-Mai Jiang; J William O Ballard; Martin P Horan; Zhi Ming Fang; Beng H Chong; Daniel Kam Yin Chan
Journal:  Neurotox Res       Date:  2013-09-12       Impact factor: 3.911

3.  Self-administration of methamphetamine alters gut biomarkers of toxicity.

Authors:  Amanda Flack; Amanda L Persons; Sharanya M Kousik; T Celeste Napier; Anna Moszczynska
Journal:  Eur J Neurosci       Date:  2017-08       Impact factor: 3.386

4.  Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.

Authors:  Naomi P Visanji; Connie Marras; Drew S Kern; Amaal Al Dakheel; Andrew Gao; Louis W C Liu; Anthony E Lang; Lili-Naz Hazrati
Journal:  Neurology       Date:  2015-02-10       Impact factor: 9.910

5.  Parkinson's disease and colorectal cancer risk-A nested case control study.

Authors:  Ben Boursi; Ronac Mamtani; Kevin Haynes; Yu-Xiao Yang
Journal:  Cancer Epidemiol       Date:  2016-05-24       Impact factor: 2.984

6.  Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects.

Authors:  Thomas G Beach; Anne-Gaëlle Corbillé; Franck Letournel; Jeffrey H Kordower; Thomas Kremer; David G Munoz; Anthony Intorcia; Joseph Hentz; Charles H Adler; Lucia I Sue; Jessica Walker; Geidy Serrano; Pascal Derkinderen
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

7.  Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.

Authors:  Chong-Bin Zhong; Qian-Qian Chen; Caroline Haikal; Wen Li; Alexander Svanbergsson; Meike Diepenbroek; Jia-Yi Li
Journal:  Neurosci Bull       Date:  2017-09-18       Impact factor: 5.203

Review 8.  Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle?

Authors:  Amol Sharma; Julie Kurek; John C Morgan; Chandramohan Wakade; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2018-01-19

9.  α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.

Authors:  Joong-Seok Kim; In-Seok Park; Hyung-Eun Park; Su-Young Kim; Jung A Yun; Chan Kwon Jung; Hye-Young Sung; Jin-Kwon Lee; Won-Kyung Kang
Journal:  Neurol Sci       Date:  2016-11-01       Impact factor: 3.307

10.  Subtle Esophageal Motility Alterations in Parkinsonian Syndromes: Synucleinopathies vs. Tauopathies.

Authors:  Inga Claus; Judith Suttrup; Paul Muhle; Sonja Suntrup-Krueger; Marie-Luise Siemer; Frank Lenze; Rainer Dziewas; Tobias Warnecke
Journal:  Mov Disord Clin Pract       Date:  2018-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.